Non‐steroidal anti‐inflammatory drugs for acute gout

CMPG van Durme, MD Wechalekar… - Cochrane Database …, 2014 - cochranelibrary.com
Background Gout is an inflammatory arthritis that is characterised by the deposition of
monosodium urate crystals in synovial fluid and other tissues. The natural history of articular …

NSAIDs/nitazoxanide/azithromycin repurposed for COVID-19: potential mitigation of the cytokine storm interleukin-6 amplifier via immunomodulatory effects

MT Kelleni - Expert Review of Anti-infective Therapy, 2022 - Taylor & Francis
Introduction Mediators of immunity and inflammation are playing a crucial role in COVID-19
pathogenesis and complications as demonstrated by several genetic and clinical studies …

[HTML][HTML] Global, regional, and national prevalence of gout from 1990 to 2019: age-period-cohort analysis with future burden prediction

Q He, TN Mok, TH Sin, J Yin, S Li, Y Yin… - JMIR Public Health …, 2023 - publichealth.jmir.org
Background: Gout is a common and debilitating condition that is associated with significant
morbidity and mortality. Despite advances in medical treatment, the global burden of gout …

Evaluating the safety and short-term equivalence of colchicine versus prednisone in older patients with acute calcium pyrophosphate crystal arthritis (COLCHICORT) …

T Pascart, P Robinet, S Ottaviani, R Leroy… - The Lancet …, 2023 - thelancet.com
Background Acute calcium pyrophosphate crystal arthritis causes intense joint pain mainly
affecting older people. Because guidance and evidence remain scarce, management of this …

Can NSAIDs and acetaminophen effectively replace opioid treatment options for acute pain?

JV Pergolizzi, P Magnusson, JA LeQuang… - Expert Opinion on …, 2021 - Taylor & Francis
Introduction Opioid analgesia for acute painful conditions has come under increasing
scrutiny with the public health crisis of opioid overdose, leading clinicians to seek nonopioid …

2021 Asia‐Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout

JPP Lorenzo, MHMZ Sollano, EO Salido… - … journal of rheumatic …, 2022 - Wiley Online Library
Background Gout is the most prevalent inflammatory arthritis in the Asia‐Pacific region and
worldwide. This clinical practice guideline (CPG) aims to provide recommendations based …

Pragmatic trials of pain therapies: a systematic review of methods

D Hohenschurz-Schmidt, BA Kleykamp, J Draper-Rodi… - Pain, 2022 - journals.lww.com
Pragmatic randomised clinical trials aim to directly inform clinical or health policy decision
making. Here, we systematically review methods and design of pragmatic trials of pain …

Management and cure of gouty arthritis

SF Keller, BF Mandell - Medical Clinics, 2021 - medical.theclinics.com
With a prevalence of 3.9% among all adults, and 9.7% in those older than 80, gout is the
most common inflammatory arthritis. 1 An analysis of National Health and Nutrition …

Colchicine for the treatment of COVID-19 patients: efficacy, safety, and model informed dosage regimens

E Karatza, G Ismailos, V Karalis - Xenobiotica, 2021 - Taylor & Francis
Colchicine is widely investigated for cardioprotection of COVID-19 patients since it can
prevent the phenomenon of 'cytokine storm'and may reduce the complications arising from …

Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) common language definition of gout

R Murdoch, MJ Barry, HK Choi, D Hernandez… - RMD open, 2021 - rmdopen.bmj.com
Objective To develop a Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-
CAN) common language definition of gout, with the goal of increasing public understanding …